SYNERGY™ & SYNERGY MEGATRON™
EES PtCr Coronary Stent System
SYNERGY BP Stent showed numerically lowest ST rates compared to other DES despite being used in patients with more complex disease
| SYNERGY Stent | DES | p | |
|---|---|---|---|
| N patients | 4,247 |
38,110 |
<0.01 |
| Class B2/C Lesions | 59% |
54% |
<0.01 |
| LM | 6.9% |
6.1% |
NS |
| CTO | 4.8% |
4.1% |
NS |
| 2VD | 30.0% |
29.4% |
NS |
Diabetes |
23.1% |
21.9% |
<0.01 |
Prior PCI |
31.2% |
29.2% |
<0.01 |
3VD |
17.4% |
16.6% |
<0.01 |
Stent Diameter |
2.95 mm |
3.00 mm |
<0.01 |
Stent Length |
22.32 mm |
20.32 mm |
<0.01 |
SYNERGY BP Stent showed numerically lowest ST rates compared to other new-generation DES despite use in more complex patients with AMI
| SYNERGY BP Stent | n-DES | p | |
|---|---|---|---|
| N patients† | 4,889 |
31,403 |
|
| Previous MI | 24.6% |
22.1% |
<0.001 |
| Previous PCI | 21.9% |
19.3% |
<0.001 |
| Left Main | 5.5% |
4.8% |
0.026 |
| 3VD | 25.1% |
22.2% |
<0.001 |
Restenotic lesion |
6.3% |
4.8% |
<0.001 |
Multivessel PCI |
23.9% |
20.7% |
<0.001 |
SYNERGY Stent demonstrated the lowest ST rates in patients with ACS
Optimal Healing
Advanced design for optimal healing
Clinical Program
Addressing the full spectrum of cardiovascular disease complexity